001     137000
005     20240229105110.0
024 7 _ |a 10.1002/ijc.31563
|2 doi
024 7 _ |a pmid:29696648
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:40108231
|2 altmetric
037 _ _ |a DKFZ-2018-01428
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Murphy, Neil
|0 0000-0003-3347-8249
|b 0
245 _ _ |a A prospective evaluation of plasma polyphenol levels and colon cancer risk.
260 _ _ |a Bognor Regis
|c 2018
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1537183888_17423
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Polyphenols have been shown to exert biological activity in experimental models of colon cancer; however, human data linking specific polyphenols to colon cancer is limited. We assessed the relationship between pre-diagnostic plasma polyphenols and colon cancer risk in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition study. Using high pressure liquid chromatography coupled to tandem mass spectrometry, we measured concentrations of 35 polyphenols in plasma from 809 incident colon cancer cases and 809 matched controls. We used multivariable adjusted conditional logistic regression models that included established colon cancer risk factors. The false discovery rate (qvalues ) was computed to control for multiple comparisons. All statistical tests were two-sided. After false discovery rate correction and in continuous log2 -transformed multivariable models, equol (odds ratio [OR] per log2 -value, 0.86, 95% confidence interval [95% CI] = 0.79-0.93; qvalue  = 0.01) and homovanillic acid (OR per log2 -value, 1.46, 95% CI = 1.16-1.84; qvalue  = 0.02) were associated with colon cancer risk. Comparing extreme fifths, equol concentrations were inversely associated with colon cancer risk (OR = 0.61, 95% CI = 0.41-0.91, ptrend  = 0.003), while homovanillic acid concentrations were positively associated with colon cancer development (OR = 1.72, 95% CI = 1.17-2.53, ptrend  < 0.0001). No heterogeneity for these associations was observed by sex and across other colon cancer risk factors. The remaining polyphenols were not associated with colon cancer risk. Higher equol concentrations were associated with lower risk, and higher homovanillic acid concentrations were associated with greater risk of colon cancer. These findings support a potential role for specific polyphenols in colon tumorigenesis.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Achaintre, David
|b 1
700 1 _ |a Zamora-Ros, Raul
|0 0000-0002-6236-6804
|b 2
700 1 _ |a Jenab, Mazda
|b 3
700 1 _ |a Boutron-Ruault, Marie-Christine
|b 4
700 1 _ |a Carbonnel, Franck
|b 5
700 1 _ |a Savoye, Isabelle
|b 6
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 7
|u dkfz
700 1 _ |a Kühn, Tilman
|0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
|b 8
|u dkfz
700 1 _ |a Boeing, Heiner
|b 9
700 1 _ |a Aleksandrova, Krasimira
|b 10
700 1 _ |a Tjønneland, Anne
|b 11
700 1 _ |a Kyrø, Cecilie
|0 0000-0002-9083-8960
|b 12
700 1 _ |a Overvad, Kim
|b 13
700 1 _ |a Quirós, J Ramón
|b 14
700 1 _ |a Sánchez, Maria-Jose
|b 15
700 1 _ |a Altzibar, Jone M
|b 16
700 1 _ |a María Huerta, José
|b 17
700 1 _ |a Barricarte, Aurelio
|b 18
700 1 _ |a Khaw, Kay-Tee
|b 19
700 1 _ |a Bradbury, Kathryn E
|0 0000-0003-3345-7333
|b 20
700 1 _ |a Perez-Cornago, Aurora
|0 0000-0002-5652-356X
|b 21
700 1 _ |a Trichopoulou, Antonia
|b 22
700 1 _ |a Karakatsani, Anna
|b 23
700 1 _ |a Peppa, Eleni
|b 24
700 1 _ |a Palli, Domenico
|0 0000-0002-5558-2437
|b 25
700 1 _ |a Grioni, Sara
|b 26
700 1 _ |a Tumino, Rosario
|b 27
700 1 _ |a Sacerdote, Carlotta
|0 0000-0002-8008-5096
|b 28
700 1 _ |a Panico, Salvatore
|b 29
700 1 _ |a Bueno-de-Mesquita, H B As
|b 30
700 1 _ |a Peeters, Petra H
|b 31
700 1 _ |a Rutegård, Martin
|b 32
700 1 _ |a Johansson, Ingegerd
|b 33
700 1 _ |a Freisling, Heinz
|b 34
700 1 _ |a Noh, Hwayoung
|b 35
700 1 _ |a Cross, Amanda J
|b 36
700 1 _ |a Vineis, Paolo
|b 37
700 1 _ |a Tsilidis, Kostas
|b 38
700 1 _ |a Gunter, Marc J
|b 39
700 1 _ |a Scalbert, Augustin
|b 40
773 _ _ |a 10.1002/ijc.31563
|g Vol. 143, no. 7, p. 1620 - 1631
|0 PERI:(DE-600)1474822-8
|n 7
|p 1620 - 1631
|t International journal of cancer
|v 143
|y 2018
|x 0020-7136
909 C O |o oai:inrepo02.dkfz.de:137000
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2015
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21